What's new
●February 1, 2012
Financial Results for the Ｔhird Quarter of Fiscal Year 03/2012
R&D Pipeline as of February 2012
●December 12, 2011
Transfer of Distribution Rights for Antiparkinson’s Disease Agent "CABASER
®
Tab. 0.25mg・1.0mg"
About Kissei
Message
Company Profile
KISSEI's History
Cultural Activities
Research & Development
About R&D
Central Research Lab.
Toxicological Lab.
Joetsu Chemical Lab.
Pharmaceutical Lab.
R&D Pipeline
New Drug Ideas Invited
Investor Relations
News Release
Financial Summary
Annual Report
